Production (Stage)
MedMira Inc.
MIR.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 182.50K | 201.00K | 262.50K | 304.10K | 283.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 182.50K | 201.00K | 262.50K | 304.10K | 283.40K |
| Cost of Revenue | 682.30K | 702.60K | 749.20K | 757.60K | 687.80K |
| Gross Profit | -499.80K | -501.60K | -486.70K | -453.50K | -404.40K |
| SG&A Expenses | 1.29M | 1.26M | 1.15M | 1.09M | 859.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.87M | 2.82M | 2.49M | 2.20M | 1.88M |
| Operating Income | -2.69M | -2.62M | -2.23M | -1.89M | -1.60M |
| Income Before Tax | -3.35M | -3.23M | -2.82M | -2.45M | -2.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.35 | -3.23 | -2.82 | -2.45 | -2.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.35M | -3.23M | -2.82M | -2.45M | -2.31M |
| EBIT | -2.69M | -2.62M | -2.23M | -1.89M | -1.60M |
| EBITDA | -2.51M | -2.46M | -2.08M | -1.76M | -1.47M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.81B | 2.81B | 2.80B | 2.80B | 2.79B |
| Average Diluted Shares Outstanding | 2.81B | 2.81B | 2.80B | 2.80B | 2.79B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |